Some opponents of marijuana policy reform have manipulated the Speaker’s comments to imply that she was opining that cannabis therapy has been proven specifically to be successful for the treatment of COVID-19.
Later this month, there will be a crucial vote in the US House of Representatives…
NORML leadership today sent an open letter to Nora D. Volkow, M.D., Director of the US National Institute on Drug Abuse (NIDA), asking her to recognize the detrimental impact that racially-discriminatory marijuana law enforcement has had on the public health of communities of color.
If you haven’t read our statement on the murder of George Floyd and the intersections…
Ten members of the Senate, led by Senators Jacky Rosen (D-NV) and Ron Wyden (D-OR), and 34 members of the House, led by Representatives Earl Blumenauer (D-OR) and Tom McClintock (R-CA), have recently issued letters requesting Small Business Administration funding programs be expanded so that they may be accessed by state-licensed cannabis businesses.
“These totals affirm that targeting marijuana-related growing operations still remains a DEA priority, even at a time when most Americans have made it clear that they want cannabis policies to head in a very different direction.”
“We believe that the adoption of these rules may further stonewall efforts to advance our scientific understanding of cannabis by unduly expanding the DEA’s authority and control over decisions that ought to be left up to health experts and scientists.”
Delaware NORML sparked up the community for a call to action, urging Governor Carney to offer delivery options to adequately serve medical cannabis patients in this time of crisis.